Slap activators refer to a category of chemical agents that enhance the activity of the Src-like adaptor protein (Slap), which is involved in the regulation of various cellular signaling pathways, particularly those mediated by receptor tyrosine kinases (RTKs). Slap functions as an adaptor protein that can negatively regulate RTKs through interactions that promote their ubiquitination and subsequent degradation, thus attenuating signaling.
Direct Slap activators would typically increase the activity of Slap by binding to it and inducing a conformational change that augments its affinity for its substrates or interaction partners, such as RTKs or components of the ubiquitination machinery. These activators might also mimic or stabilize the active form of Slap, facilitating its function in the downregulation of receptor signaling. Indirect activators of Slap might exert their effects through modulation of cellular signaling pathways that influence the expression levels or post-translational modification of Slap. For instance, they could activate upstream kinases that phosphorylate Slap, which may be necessary for its full activation. Additionally, these activators might inhibit phosphatases that dephosphorylate Slap, thus maintaining Slap in a more active state.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC) which can lead to activation of signaling cascades in which SLAP participates. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP, which can regulate PKA. PKA further affects various signaling pathways, potentially influencing SLAP. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, which can maintain phosphorylation of proteins in signaling pathways where SLAP operates. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine can activate PKC at low doses. PKC, in turn, can activate signaling cascades involving SLAP. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases, maintaining the phosphorylated state of proteins in signaling pathways where SLAP is involved. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits PDE4, leading to increased cAMP levels and PKA activation, potentially influencing SLAP. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
KT5720 inhibits PKA, which can modulate signaling cascades and indirectly affect the activity of SLAP. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic acid can activate PKC, which can influence signaling cascades involving SLAP. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a PKC inhibitor. Inhibition of PKC can modulate signaling cascades and indirectly affect the activity of SLAP. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can influence intracellular Ca2+ concentrations, affecting PKC and, subsequently, signaling pathways involving SLAP. | ||||||